World’s first transdermal insulin shows promise

a growing number of new contenders vying to cash in on the non-injectable insulin field, competing with pharma giants such as Pfizer who have recently launched the first inhalable form of insulin, however, the firm believes it has developed a drug delivery technology that is unique, being able to deliver large-size insulin molecules through the skin's surface, without the need for burdensome and expensive drug delivery devices.

“We can deliver a molecule up to 40,000 daltons in size